Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer

Status Completed

Clinical Trial Summary

This phase I study is designed to determine the maximum tolerant dose of capecitabine when used in preoperative concurrent chemo-radiation for locally advanced rectal patients over 75 years old.

Clinical Trial Description

It is proved that preoperative concurrent chemo-radiotherapy can improve both local control and overall survival in stage II/III rectal cancer patients. But elderly patients, especially patients over 75 years were hardly involved in related clinical trials considered of their fragility.

Several retrospective study showed that old rectal cancer patients would also benefit from concurrent chemo-radiation, with acceptable toxicity. Several new drug, such as capecitabine, also seem to be safety for elderly cancer patients. But few prospective study has been carried out.

The investigators designed this phase I study, to explore the maximum tolerant dose of capecitabine in preoperative concurrent chemoradiation for elderly stage II/III rectal cancer patients, as well as to evaluate safety. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Rectal Neoplasms

Clinical Trial Details

NCT number	NCT01584544
Study type	Interventional
Source	Chinese Academy of Medical Sciences
Contact
Status	Completed
Phase	Phase 1
Start date	January 2011
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02537340` - PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR
Recruiting	`NCT02565667` - A Prospective Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL Stapler	N/A
Not yet recruiting	`NCT02439086` - Prediction of Response to Neoadjuvant Therapy in Rectal Cancer	N/A
Terminated	`NCT02538913` - Exercise Training for Rectal Cancer Patients	N/A
Completed	`NCT02233374` - Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Completed	`NCT00535041` - Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA	N/A
Recruiting	`NCT04949646` - Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision	N/A
Recruiting	`NCT04095468` - Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
Recruiting	`NCT06017583` - Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer	Phase 3
Recruiting	`NCT05689775` - Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
Recruiting	`NCT04006951` - Development of a Clinical and Biological Database in Rectum Cancer	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03714490` - MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer	Phase 2
Recruiting	`NCT03325361` - The Role of Transanal Tube Drainage as A Mean of Prevention of Anastomotic Leakage Anastomotic Leakage	N/A
Completed	`NCT02252250` - Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer	N/A
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT04455737` - Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
Completed	`NCT01721785` - Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer	N/A
Active, not recruiting	`NCT01171300` - Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients	N/A